Jie Xu

24PUBLICATIONS
31CO-AUTHORS
Haematological tumoursGenetics not elsewhere classifiedPredictive and prognostic markersAutoimmunityApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (24)

|Jul 13, 2023
T-prolymphocytic leukemia: TCL1 or MTCP1 rearrangement is not mandatory to establish diagnosis.

Hong Fang, Hannah C Beird, Sa A Wang

|Dec 13, 2022
High-grade B-cell lymphoma (HGBL)-NOS is clinicopathologically and genetically more similar to DLBCL/HGBL-DH than DLBCL.

Shaoying Li, Lianqun Qiu, Jie Xu

|Feb 28, 2022
Single-cell transcriptomic profiling unravels the adenoma-initiation role of protein tyrosine kinases during colorectal tumorigenesis.

Xiaobo Zheng, Jinen Song, Chune Yu

|Oct 10, 2021
Small cell/lymphohistiocytic morphology is associated with peripheral blood involvement, CD8 positivity and retained T-cell antigens, but not outcome in adults with ALK+ anaplastic large cell lymphoma.

Mahsa Khanlari, Shaoying Li, Roberto N Miranda

|Oct 05, 2021
Blastoid high-grade B-cell lymphoma initially presenting in bone marrow: a diagnostic challenge.

Mahsa Khanlari, L Jeffrey Medeiros, Pei Lin

|Aug 30, 2021
A peptidic inhibitor for PD-1 palmitoylation targets its expression and functions.

Han Yao, Chushu Li, Fang He

Pageof 4

Frequent Collaborators

10 joint publications

Shaoying Li

7 joint publications

Roberto N Miranda

5 joint publications

L Jeffrey Medeiros

3 joint publications

Joseph D Khoury